In the BioHarmony Drug Report Database

"Preview" Icon

Finafloxacin

Xtoro (finafloxacin) is a small molecule pharmaceutical. Finafloxacin was first approved as Xtoro on 2014-12-17. It is used to treat otitis externa and staphylococcal infections in the USA. Xtoro’s patent is valid until 2033-11-21 (FDA).

 

Trade Name

 

Xtoro
 

Common Name

 

finafloxacin
 

ChEMBL ID

 

CHEMBL1908370
 

Indication

 

otitis externa, staphylococcal infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Finafloxacin structure rendering